Kevin Kuo

Assistant Professor (status)

University of Toronto

Canada

Research Interests

Explore related searches

Professors in Canada

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (19)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Collaborators (8)

Clodagh Ryan

Assistant Professor

University of Toronto

CANADA

View details

Jameel Abdulrehman

University of Toronto Faculty of Medicine

CANADA

View details

Stéphanie Forté

Centre Hospitalier de l'Université de Montréal Centre de Recherche

CANADA

View details

Owen Lyons

Assistant Professor

University of Toronto

CANADA

View details

Ann Kinga Malinowski

University of Toronto

CANADA

View details

Satheesh Chonat

UNITED STATES

View details

Pablo Bartolucci

Institut Mondor de recherche biomédicale

FRANCE

View details

Andreas Glenthøj

DENMARK

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Kevin Kuo

Research Interests

Explore related searches

Contact this professor

Articles (19)

Iron chelation therapy for children with transfusion-dependent β-thalassemia: How young is too young?

Comorbidities and complications in adult and paediatric patients with pyruvate kinase deficiency: Analysis from the Peak Registry

Designing a single-arm phase 2 clinical trial of mitapivat for adult patients with erythrocyte membranopathies (SATISFY): a framework for interventional trials in rare anaemias - pilot study protocol

Clinically meaningful improvements in patient-reported outcomes in mitapivat-treated patients with pyruvate kinase deficiency

Mitapivat improves ineffective erythropoiesis and iron overload in adult patients with pyruvate kinase deficiency

Blood pressure thresholds for the diagnosis of hypertensive disorders of pregnancy in sickle cell disease

Bone mineral density in adult patients with pyruvate kinase deficiency on long-term mitapivat treatment

Corrigendum to “Activation of pyruvate kinase as therapeutic option for rare hemolytic anemias: Shedding new light on an old enzyme” [Blood Rev. 2023 Sep:61:101103] (Blood Reviews (2023) 61, (S0268960X23000644), (10.1016/j.blre.2023.101103))

Diagnosis and management of pyruvate kinase deficiency: international expert guidelines

Αlpha-thalassemia: A practical overview

Early Strokes Are Associated with More Global Cognitive Deficits in Adults with Sickle Cell Disease

A systematic review comparing allogeneic hematopoietic stem cell transplant to gene therapy in sickle cell disease

Systematic review of outcome reporting in studies of SCD and pregnancy: marked heterogeneity hinders meaningful data synthesis

Thromboprophylaxis Reduced Venous Thromboembolism in Sickle Cell Patients with Central Venous Access Devices: A Retrospective Cohort Study

Prevalence of elevated hemoglobin and hematocrit levels in patients with obstructive sleep apnea and the impact of treatment with continuous positive airway pressure: a meta-analysis

Health-related quality of life and fatigue in children and adults with pyruvate kinase deficiency

Distinct maternal and fetal pregnancy outcomes in women with sickle cell disease can be predicted using routine clinical and laboratory data

The pyruvate kinase (PK) to hexokinase enzyme activity ratio and erythrocyte PK protein level in the diagnosis and phenotype of PK deficiency

Impact of MRI technique on clinical decision-making in patients with liver iron overload: comparison of FerriScan- versus R2*-derived liver iron concentration

Collaborators (8)

Clodagh Ryan

Jameel Abdulrehman

Stéphanie Forté

Owen Lyons

Ann Kinga Malinowski

Satheesh Chonat

Pablo Bartolucci

Andreas Glenthøj

Make your next move.